Home › Funds › Boxer Capital Management, LLC › KZIA
Boxer Capital Management, LLC position in KZIA
KAZIA THERAPEUTICS LTD · Health Care
Boxer Capital Management, LLC reported holding 371,500 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.31% of its reported portfolio and ranking #34 among its reported holdings. Boxer Capital Management, LLC has disclosed KZIA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's KZIA position evolved
Boxer Capital Management, LLC first disclosed a stake in KZIA in Q2 2026 at 560,000 shares (US$7.9M). Across 2 filings, Boxer Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 371,500 shares valued at US$3.6M — a reduction of -188,500 shares quarter over quarter.. Notable position changes include a 34% trim in Q3 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 560.00K | $7.88M | New |
| Q3 2026 | 371.50K | $3.56M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KZIA and 13F data
KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 60 other funds we track also report a position in KZIA — the largest reported positions include Dauntless Investment Group, LLC (US$8.3M), Bleichroeder LP (US$4.7M), Stonepine Capital Management, LLC (US$3.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KZIA
- Dauntless Investment Group, LLC 866.22K sh · $8.31M · Q3 2026
- Bleichroeder LP 490.41K sh · $4.71M · Q3 2026
- Stonepine Capital Management, LLC 377.43K sh · $3.62M · Q3 2026
- Lynx1 Capital Management LP 225.80K sh · $2.17M · Q3 2026
- Knoll Capital Management, LLC 129.00K sh · $1.24M · Q3 2026
- Kalehua Capital Management LLC 56.01K sh · $537.45K · Q3 2026
- COOPERMAN LEON G 50.00K sh · $479.75K · Q3 2026
- ACT Capital Partners, L.P. 35.00K sh · $335.82K · Q3 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held KZIA?
Boxer Capital Management, LLC has disclosed KZIA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Boxer Capital Management, LLC's current position in KZIA?
As of Q3 2026, Boxer Capital Management, LLC holds 371.50K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $3.56M, representing 0.31% of its reported portfolio and ranking #34.
Has Boxer Capital Management, LLC been buying or selling KZIA?
In the latest 13F filing (Q3 2026), Boxer Capital Management, LLC reduced its position in KZIA.
Which other funds hold KZIA?
Other major institutional holders of KZIA include Dauntless Investment Group, LLC, Bleichroeder LP, Stonepine Capital Management, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.